Communication from the Commission to the Council, the European Parliament and the European Economic and Social Committee on combating HIV/AIDS within the European Union and in the neighbouring countries, 2006-2009. COM (2005) 654 final, 15 December 2005 by unknown
 
EN     EN 
 
COMMISSION OF THE EUROPEAN COMMUNITIES 
Brussels, 15.12.2005 
COM(2005) 654 final 
  
COMMUNICATION FROM THE COMMISSION 
TO THE COUNCIL AND THE EUROPEAN PARLIAMENT 
on combating HIV/AIDS within the European Union and in the neighbouring countries, 
2006-2009  
EN  2     EN 
COMMUNICATION FROM THE COMMISSION 
TO THE COUNCIL AND THE EUROPEAN PARLIAMENT 
on combating HIV/AIDS within the European Union and in the neighbouring countries, 
2006-2009 
1.  INTRODUCTION 
This communication builds on the principles and priorities set out in the Commission 
working paper “Coordinated and integrated approach to combat HIV/AIDS within 
the European Union and in its neighbourhood” and sets out the main lines for action 
until the end of 2009. A more detailed action plan for the present phase is included in 
the Annex. Many of these activities have to be completed with partners and require 
the close involvement of players within Member States. This document brings 
together the relevant EU policies and instruments available, which play a role in 
combating HIV/AIDS. Concerning external action, this Communication is fully 
consistent with and contributes to implementing the overall policy framework
i 
HIV/AIDS strategies are closely linked to strengthening the general European values 
on human security and the protection of human rights, including sexual and 
reproductive rights, the rights of minorities and the fundamental rights of migrants, 
refugees and displaced persons. 
In this document the overall aims stated in the thematic chapters (Chapters 2 to 6) 
reflect the commitments made in the UNGASS
ii, Dublin and Vilnius
iii Declarations. 
Chapter 7 explores the possibilities to enhance implementation of HIV/AIDS policies 
in Russia and the area covered by the European Neighbourhood Policy.
iv. The last 
chapter (Chapter 8) outlines the commitments ahead for all the partners and describes 
the possibilities for monitoring progress. 
The state of the HIV/AIDS epidemic in Europe and the Mediterranean area is shown 
in Figure 1. Fuller details on the evolution of the epidemic can be found on 
www.eurohiv.org.  
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The Commission is concerned about the diminished focus on prevention, which 
remains the cornerstone for all other activities within the comprehensive approach to 
tackle HIV/AIDS. Without vigorous promotion of primary prevention measures, like 
education, the use of condoms and implementation of harm reduction measures (such 
as exchange of needles and syringes), any other targets set (such as the elimination of 
mother-to-child transmission or universal access to treatment) cannot be achieved. 
The other areas of action which need strengthening are human rights issues, 
surveillance, and actions targeted at specific vulnerable groups
v. 
Providing political leadership and advocacy is the main value added of the EU 
activities on HIV/AIDS. The Commission will continue to keep HIV/AIDS and 
related issues on the wide political agenda and provide leadership to combat stigma 
and discrimination, and promote the provision of universal access to prevention 
services, ARV treatment and harm reduction services for injecting drug users. 
Coordination, facilitating the development of a common knowledge base, provision 
of common tools for decision-making and additional funds to support national 
activities and research and development programmes in this field are other areas 
where joint action at EU/European level can add value to the work done elsewhere.  
2.  INVOLVEMENT OF CIVIL SOCIETY  
The aim is to strengthen the involvement of civil society in all aspects of the response 
to the epidemic, including policy development, implementation, monitoring, and 
evaluation.  
********** 
Since Dublin the Commission has involved civil society
vi organisations in the 
HIV/AIDS Think Tank, which has now established a HIV/AIDS Civil Society  
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Forum which met for the first time in September 2005. This is an informal working 
group to facilitate the participation of non-governmental organisations, including 
those representing people living with HIV/AIDS, in policy development and 
implementation and in information exchange activities. The Forum includes 30 
organisations from all over Europe representing different fields of activity. 
Action 
The Commission will actively involve civil society, and in particular people living 
with HIV/AIDS, in policy development, implementation and monitoring. The 
Commission invites regional and national authorities to facilitate the sustainability of 
the non-governmental and community-based organisations
vii and their involvement in 
policy development, implementation, and monitoring both within the EU and in other 
European countries.  
Partnership with the private sector 
For many businesses HIV/AIDS is already having an impact on their 
competitiveness. For others the potential risks are significant no matter whether 
HIV/AIDS prevalence is high or low. According to a survey conducted by the World 
Economic Forum
viii in 2004, 10% of executives in Western Europe believe that 
HIV/AIDS will have some impact on their business, compared to 19% in Eastern 
Europe. 
The Commission has established partnerships with the Alliance for Microbicide 
Development and Global HIV Vaccine Enterprise and has initiated collaboration 
with the Global Business Coalition, the pharmaceutical industry and other supportive 
businesses in order to define areas where they could work together to combat 
HIV/AIDS. 
Action 
The Commission invites European businesses through the Union des Industries de la 
Communauté Européenne
1ix (UNICE) and other means, to strengthen their response 
to the epidemic and to play their role in implementing this strategy. 
3.  SURVEILLANCE 
The aim is: 
•  to improve and harmonise surveillance systems to track and monitor the epidemic, 
risk behaviour and vulnerability to HIV/AIDS; 
•  to contribute to the provision of incidence and prevalence data and information 
on other sexually transmitted infections, hepatitis C, hepatitis B and tuberculosis, 
particularly amongst those at the highest risk and most vulnerable; 
•  to support surveillance of HIV testing. 
**********  
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Surveillance of HIV/AIDS in Europe is currently coordinated by the EuroHIV
x 
surveillance network which is co-financed by the European Commission under the 
Public Health Programme
xi. In 2008 the European Centre for Disease Prevention and 
Control (ECDC)
xii will take responsibility for the network. As one of the ECDC’s 
tasks is to operate the surveillance networks in an integrated way, overlaps and 
synergies between surveillance of HIV, tuberculosis, other sexually transmitted 
infections (STIs) and hepatitis B (HBV) and hepatitis C (HCV) will be addressed.  
HIV case reporting has evolved into the key instrument for monitoring the epidemic 
in Europe. It is therefore crucial to have data from all European countries, which is 
not the case at the moment. Better strategies and more targeted measures need better 
information on the behavioural risk factors, like condom use or exchanges of needles 
and syringes. In countries with low HIV prevalence, surveillance should also be 
organised in a way to detect early signs of the entry of HIV into the population 
groups more exposed to risk of infection. To help plan future treatment and service 
needs, the true number of new HIV infections per year [HIV incidence] should also 
be known. At the moment the majority of the newly reported cases are in fact 
infections contracted many years ago. 
The capacity for monitoring the susceptibility of HIV to ARV drugs should be 
developed into an integral part of HIV surveillance at national and European level. 
Action  
The Commission will promote surveillance as an important basis for any strategies 
and policies to combat HIV/AIDS. 
The Commission will support, through existing structures
xiii, collection and analysis 
of susceptibility data and, to this end, facilitate use of the existing EU financial 
instruments. 
Member States should ensure the availability of resources [human, financial, 
equipment] and capability to achieve this and, to this end, consider use of the EU 
financial instruments. 
The Commission will, in close collaboration with the ECDC, Member States, 
neighbouring countries and other partners: 
•  facilitate completion of the geographic coverage of HIV case reporting;  
•  reassess the objectives of AIDS surveillance and include its reporting in an 
integrated surveillance system; 
•  design a standardised approach for appropriate prevention indicators; 
•  develop estimates of HIV incidence in Europe; 
•  facilitate the setting-up of sentinel surveillance 
xiv in high-risk groups; 
•  facilitate implementation of practical solutions to address the confidentiality 
obstacles.  
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4.  PREVENTION OF NEW HIV INFECTIONS  
The aim is: 
•  to facilitate the implementation of population-wide and targeted HIV prevention 
measures; 
•  to ensure that all citizens have access to information, education and services to 
reduce their vulnerability to HIV/AIDS; 
•  to scale up access to prevention, drug dependence treatment and harm reduction 
services for injecting drug users;  
•  to address the specific needs and requirements of migrant populations for non-
discriminating access to information and prevention, treatment, care and support; 
•  to support the monitoring and evaluation of prevention methods. 
********** 
As there is no vaccine or curative treatment, prevention remains the cornerstone in 
the fight against HIV/AIDS. Wide implementation of primary prevention activities, 
education, promotion of condom use, implementation of harm reduction services and 
access to voluntary counselling and testing are imperative in order to attain the 
targets set in other areas. There is evidence from many European countries that the 
spread of HIV can be prevented, curbed or reversed through the implementation of 
proven, evidence-based intervention. 
Based on HIV epidemiology within the EU and in neighbouring countries there is a 
need for intensified prevention measures for the general public, and targeted at 
specific groups such as youth, women, injecting drug users, men who have sex with 
men, commercial sex workers, prisoners, and migrant populations.  
It is estimated that comprehensive HIV prevention measures could avert 63% of the 
45 million new infections expected to occur between 2002 and 2010 globally
xv. 
While the numbers of people living with HIV/AIDS grow every year, prevention 
services are not growing at the same rate. According to United Nations estimates
xvi 
there are currently 13 million regular injecting drug users (IDU) worldwide, and in 
Russia alone an estimated 1.5 million
xvii - more than 11% of the worldwide estimate. 
Moreover, according to recent reports
xviii 7.6% of IDUs in Eastern Europe have 
access to harm reduction programmes. 
Prevention is closely linked with treatment, as greater access to ARV treatment 
reinforces HIV prevention through increased voluntary counselling and testing. This 
in turn contributes to reducing stigma and discrimination, which are still barriers to 
success. Another hindrance for success can be the effectiveness and overall quality of 
existing prevention programmes, which are still poorly evaluated and monitored. 
The prevention of mother-to-child transmission remains one of the priorities for 
action. After the Vilnius Conference
xix the Commission has consulted relevant  
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stakeholders and experts on the issue and will continue to define the areas where 
action at EU-level is needed. 
 Action   
The Commission will promote the implementation of comprehensive prevention 
programmes and their expansion to reach the most vulnerable populations. 
The Commission will give priority in work on sexual and reproductive health to 
developing innovative strategies to promote safe sex and to address the increase in 
risk-taking behaviour among young people within the Public Health Programme. 
The Commission will prepare a situation report on mother-to-child transmission in 
Europe. The need for future action will be assessed on this basis. 
4.1 Reduction of health-related harm associated with drug dependence  
The Council adopted the EU Drug Strategy for 2005-2012 in December 2004 and an 
EU Drugs Action Plan
xx for 2005-2008 implementing the Strategy in June 2005. 
Prevention of HIV/AIDS is a central issue in the Drugs Action Plan, which calls for 
integrated comprehensive programmes to be implemented at national and regional 
levels.  
EU drugs policies should be implemented in line with the policy on HIV/AIDS. 
Synergies can be found, for example, in the area of research, where the Drugs Action 
Plan calls for research on effective intervention to prevent HIV/AIDS and research 
on identifying protective factors in countries with low HIV/AIDS prevalence rates 
among drug users. 
The Commission will prepare a progress report on implementation of the 2003 
Council Recommendation on the prevention and reduction of health-related harm 
associated with drug dependence
xxi. The need for future action will be assessed on 
the basis of this report. 
Action 
The Commission invites the Member States to improve the availability of and access 
to harm reduction services in order to prevent health risks related to drug use and 
drug-related deaths.  
The Commission invites the Member States to ensure the availability of substitution 
treatment corresponding to the demand for treatment. 
4.2 Education  
Prevention of HIV and other sexually transmitted infections (STIs) is possible only if 
the knowledge is combined with healthy behavioural change. Therefore it is of 
utmost importance to include schools and other educational settings in HIV/AIDS 
prevention through their life skills health education programmes. Schools and other 
educational settings can also help reducing the stigma and discrimination attached to 
HIV/AIDS.   
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Action 
The Commission will promote the development of tailor-made training curricula for 
health care personnel and other professionals involved in services dealing with 
people living with HIV/AIDS and with populations that are particularly vulnerable to 
HIV/AIDS (including intravenous drug users and migrants). 
The Commission will facilitate implementation of the skills-based approach to 
promote effective behaviour change among youth in schools and other appropriate 
settings through the exchange of information and best practices and development of 
training modules. 
5.  VOLUNTARY COUNSELLING AND TESTING, TREATMENT, CARE AND SUPPORT  
The aim is:  
•  to combat stigma and discrimination against people living with HIV/AIDS in 
Europe; 
•  to support the provision of universal access to effective, affordable and equitable 
treatment and care, including safe antiretroviral treatment; 
•  to support the promotion of social and labour market integration for those living 
with HIV/AIDS. 
********** 
Affordable and accessible services and good treatment results reduce stigma and 
social exclusion and promote responsible sexual behaviour which, in turn, 
contributes to preventing the spread of HIV. 
There is a need for a comprehensive set of health services to provide good quality 
treatment and care. Voluntary counselling and testing (VCT) is a cornerstone for all 
services as it allows early diagnosis of HIV infection and ensures timely access to 
appropriate intervention for the infected. These services should also cover people 
living with HIV/AIDS (PLWHA) with hepatitis B, hepatitis C or tuberculosis co-
infection. Drug substitution therapy for injecting drug users (IDUs) is an important 
component of services contributing to effective treatment and care. 
PLWHA should play an active role in managing their condition (treatment 
preparedness). The services provided should be supportive, inclusive and 
empowering, giving people more control over their lives. Social services should be 
integrated with health services to the extent possible and should be sensitive to 
special vulnerable groups. 
Highly active antiretroviral therapy (HAART) makes a significant impact on the 
quality of life of PLWHA. Successful use of HAART also implies considerable 
efforts to maintain adherence to lifelong treatment plus resources to monitor 
response, drug toxicities and interactions. In several countries the lack of experienced  
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service providers to reach certain vulnerable groups, such as injecting drug users and 
migrant populations, can further complicate management of treatment. 
As the virus has the capability to develop resistance to antiretroviral agents, it is 
increasingly important to monitor the development of resistant strains. Insufficient 
laboratory capacity can be an obstacle to producing relevant susceptibility data. 
Action 
The Commission will support capacity-building among service providers. Priority will 
be given to the development of tailor-made training curricula for health-care 
personnel and other professionals involved in services dealing with people living 
with HIV/AIDS and with populations that are particularly vulnerable to HIV/AIDS. 
The Commission will support Member States in building up capacity in the non-
governmental organisations active in the field of HIV/AIDS to provide treatment 
counselling and support for better treatment preparedness. 
The Commission will facilitate the development of HIV/AIDS surveillance at 
European level in order to include specific data sets on service use and treatment 
outcome. 
The Commission will facilitate the development of a toolkit for the Member States 
providing a set of possible European models for comprehensive HIV/AIDS services. 
This toolkit could be made available to European Neighbourhood Policy partners
xxii. 
The Commission will support the efforts of the Member States concerned to ensure 
the availability of affordable ARV. Moreover, the Commission will study further 
possibilities for use in case of a public health emergency, such as a serious 
HIV/AIDS epidemic. 
6.  HIV/AIDS RESEARCH  
The aim is: 
•  to increase commitments to research and development for vaccines and 
microbicides; 
•  to invest in development of affordable and easier-to-use therapeutics and 
diagnostics to support expanded access to treatment; 
•  to support research driven by public health needs; 
•  to support the private sector (the small and medium –sized enterprises in 
particular) involvement and participation; 
•  to support the development of research into and evaluation of behavioural 
preventive methods.  
**********  
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Under the Sixth Framework Programme for research and development activities 
(FP6, 2002-2006), research on HIV/AIDS has become a top priority for the European 
Commission. Approximately EUR 50 million per year is allocated to this topic, 
financing both preventive and therapeutic approaches. Projects funded include big 
consortia, aimed at integrating and networking researchers working on new products 
to prevent and treat HIV/AIDS, and highly innovative approaches and more focussed 
research to develop new concepts for fighting the virus.  
FP6 puts emphasis on the new Member States and the Eastern European 
neighbouring countries, encouraging them to participate both in EC-funded proposals 
and in the evaluation process. One example involving them is the coordination of 
cohort studies
xxiii on treatment and follow-up of HIV-infected adults, children and 
pregnant women, HIV resistance and mother-to-child transmission. Another example 
is a Network of Excellence (NoE-new instrument under FP6) on therapeutic clinical 
trials, where participation by new Member States and Eastern European 
neighbouring countries is particularly encouraged. The network is expected to cover 
the period 2006-2010 and will aim at designing, standardising and coordinating 
clinical trials on HIV/AIDS at European level. The goal of the network should be to 
define optimum strategies for management of HIV infection and to develop 
guidelines for more efficient intervention in both Western and Eastern Europe. 
Action 
The Commission has presented a proposal for the Seventh Framework Programme 
(FP7), which will be negotiated with the EU Member States. HIV/AIDS research 
will continue to be a priority under the FP7. The Commission has proposed an 
increase in funding for the Programme and will continue to stress its importance. The 
health research will concentrate on three main pillars: biotechnology for human 
health, translational research and delivery of health care to European citizens. 
7.  NEIGHBOURHOOD  
In this document “neighbourhood” means the Russian Federation and the partners 
under the umbrella of the European Neighbourhood Policy (ENP). The ENP covers 
16 existing or potential partners: Algeria, Armenia, Azerbaijan, Belarus, Egypt, 
Georgia, Israel, Jordan, Lebanon, Libya, Moldova, Morocco, the Palestinian Authority, 
Syria, Tunisia and Ukraine.  
Elsewhere, the candidate countries are involved in the activities through the accession 
process and instruments. The Commission will explore the possibilities and practical 
ways to extend the HIV/AIDS activities to the Western Balkans and Central Asia in 
the future. 
The general principles for addressing HIV/AIDS in the neighbouring countries 
remain the same as stated in the Commission working paper. The Commission will 
support the development of strong and accountable political leadership to tackle the 
HIV/AIDS epidemic. The Commission will make optimum use of all existing 
instruments and future research and development, in particular clinical research, 
outcomes to address the needs of the partner countries better, while complying with 
the external aid procedures and mandate for action agreed in the relevant country  
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strategy papers and indicative programmes. This will allow the Commission’s 
operational departments to intervene in order to:  
•  facilitate evidence-based intervention embedded within the national strategy, work 
programme and expenditure framework jointly agreed with national authorities 
and other partners involved; 
•  join forces with other partners under such an approach to pave the way for what 
could set an example of good practices for neighbouring countries; 
•  optimise, through stronger EC involvement, use of the existing instruments such 
as the Global Fund and the European and Developing countries Clinical Trials 
Partnership (EDCTP) programme.  
The Commission furthermore plans to involve increasingly the neighbouring 
countries in the EU’s HIV/AIDS activities in order to exchange information and best 
practices. 
The Commission will ensure that appropriate internal mechanisms are established to 
ensure the coherence of the approached proposed with the interventions of external 
action at bilateral (EC, Member States, and other bilateral partners) and multilateral 
levels (WHO, UNAIDS, Global Fund), taking into account lessons learned in the 
past.  
7.1 The Russian Federation  
In 2003 the EU and Russia agreed to reinforce their cooperation by creating four 
“common spaces” under the umbrella of the Partnership and Cooperation Agreement. 
The roadmaps for the common spaces were agreed at the EU-Russia Summit in May 
2005 and will form the basis for cooperation between the EU and Russia in the years 
to come. HIV/AIDS is mentioned in the context of drug prevention policies and 
education of youth, which are both crucial elements of a comprehensive HIV/AIDS 
strategy. 
The Northern Dimension
xxiv policy promotes dialogue and practical cooperation 
between the EU, Russia, Norway, and Iceland. Health is one of the five key areas 
identified, and it has been taken forward under the Northern Dimension Partnership 
in Public Health and Social Wellbeing
xxv. HIV/AIDS has been the priority for action 
in this context, as well as within the intergovernmental cooperation in the Barents 
region
xxvi. 
Action 
The primary responsibility for the wellbeing and health of Russian citizens rests with 
the government of the Russian Federation. The process of planning specific joint 
action is based on the priorities in the common spaces roadmaps and will explore 
different options for exchanging best practices and networking in defined areas. 
The Commission will continue the dialogue at political level to facilitate the 
development of leadership and the crucial collaboration between different authorities 
to tackle HIV/AIDS.  
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The Commission invites the Russian Federation to collaborate in organising joint 
EU-Russia expert seminars on HIV/AIDS and related issues. 
The Commission invites representatives of the Russian Federation to participate in 
the HIV/AIDS Think Tank and the Civil Society Forum. 
The Commission will continue to work for the success of the Northern Dimension 
policy and to support the activities under the ND Partnership in Public Health. 
7.2 Partners under the European Neighbourhood Policy  
Each of the ENP partners is responsible for leading, designing and implementing its 
national strategies to tackle the HIV/AIDS epidemic. 
In 2004 the Commission published country reports concerning seven ENP partners 
(Israel, Jordan, Moldova, Morocco, the Palestinian Authority, Tunisia and Ukraine) 
followed by negotiation of ENP Action Plans, running three to five years, the 
implementation of which is now underway. In 2005, Country Reports were published 
on five more countries (Armenia, Azerbaijan, Egypt, Georgia, and Lebanon) and the 
development of ENP Action Plans for those countries is now ongoing. All these 
Action Plans refer to cooperation on public health, while those for Ukraine and 
Moldova also mention HIV/AIDS-related action. 
Several seriously affected countries need substantial external resources to scale up 
their intervention and technical assistance to strengthen their health systems, which is 
the prerequisite for adequate response to HIV/AIDS. 
Action 
The Commission invites the ENP partners, in particular those with an Action Plan, to 
participate in various EU activities on HIV/AIDS such as the Think Tank and the 
Civil Society Forum. 
8.  ACTION PLAN  
The European Commission proposes that the partners should take the work forward 
within the political framework outlined in the previous chapters and the specific 
action in the Action Plan (Annex), which will later be available on line and updated 
by the Commission in consultation with the HIV/AIDS Think Tank, the Civil Society 
Forum, and other relevant stakeholders. 
The Commission will make available on the public health website an overview of the 
possible financing instruments which could be used for implementation of this 
strategy. 
The Commission, together with partners (such as the Think Tank, UNAIDS, and 
WHO), will develop a set of appropriate core indicators for monitoring the process. 
The aim is to monitor not only outcomes but also the impact of these activities. This 
work will be based on the available tools and methods used
xxvii and should also 
contribute to monitoring the UNGASS Declaration of Commitments on HIV/AIDS, 
as well as the Dublin and Vilnius Declarations.  
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Annex : Action Plan (as 29/11//2005) 
Area for 
action 
Action  Indicative 
timetable 
Outcome  Main players 
1. Leadership and advocacy 
Human rights  Establish a working 
group to conceptualise 
problems and define 
where action at EU level 
is needed 
 
Second half 
of 2006 
Proposal for a list 
of priorities for 
action 
Civil society 
HIV/AIDS Think 
Tank 
Commission 
Neighbouring 
countries 
  Organise a Conference on 
HIV/AIDS and human 
rights  
Spring 2007    Council  Presidency 
Commission 
Member States 
Neighbouring 
countries 
Partners 
2. Involvement of civil society 
Participation in 
policy 
development 
and 
implementation 
HIV/AIDS Civil Society 
Forum 
Twice a 
year 
 Commission 
HIV/AIDS civil 
society 
representatives 
Participation in 
prevention and 
treatment 
Develop and implement a 
training programme for 
NGOs with a view to 
their involvement in 
ARV treatment and in 
prevention programmes 
Ready by 
mid-2007 
Training 
programme on 
treatment 
preparedness 
Training 
programme on 
prevention with 
specific focus on 
harm reduction 
measures for IDUs 
Commission 
Member States 
Non-governmental 
organisations 
  Implement the training 
programme  
From 2008 
on 
Number of NGO 
representatives 
trained annually 
Commission 
Member States 
NGOs  
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3. Surveillance 
Area for 
action 
Action  Indicative 
timetable 
Outcome  Main players 
Coverage of 
data 
Complete the geographic 
coverage of HIV case 
reporting within the EU and 
the WHO European region 
Complete the geographic 
coverage of HIV single case 
reporting within the EU and 
the WHO European region 
2006 
 
 
 
2008 
Complete 
surveillance data 
ECDC/EuroHIV 
Member States 
WHO Euro 
 
ECDC/EuroHIV 
Member States 
WHO Euro 
HIV-related 
information 
Reassess the objectives of 
HIV/AIDS surveillance in 
order to gain information on 
severe HIV-related 
morbidity, access to 
diagnosis and treatment 
2006   ECDC/EuroHIV   
Member States 
System 
development 
Develop an integrated 
database for HIV and AIDS 
surveillance 
2007-2008 Integrated 
database 
ECDC/EuroHIV  
 
Developing 
behavioural 
data 
collection 
Start with establishing an 
inventory of behavioural 
surveys/surveillance already 
existing in each country 
2006 Inventory  of 
available methods 
ECDC/EuroHIV  
Member States 
UNAIDS 
EMCDDA 
  Establish a list of important 
prevention indicators to be 
collected on an annual basis 
(e.g. % of IDUs sharing 
equipment in the past x 
months, % of MSM having 
unprotected anal intercourse 
at last sex) 
2007-2009 
 
Data on 
behavioural risk 
factors 
ECDC/EuroHIV  
Member States 
UNAIDS 
EMCDDA 
Sentinel 
surveillance 
for early 
warning 
Facilitate the setting-up of 
sentinel surveillance in high-
risk groups in countries with 
a low-level epidemic  
2006 Number  of 
countries with 
sentinel 
surveillance 
ECDC/EuroHIV  
Countries concerned  
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HIV 
incidence 
Estimate HIV incidence in 
Europe  
2007 True HIV 
incidence in 
Europe 
ECDC/EuroHIV 
WHO Euro 
3. Surveillance (cont’d) 
Area for 
action 
Action  Indicative 
timetable 
Outcome  Main players 
HIV 
prevalence 
Provide HIV prevalence 
estimates for Europe  
2006 HIV  prevalence 
estimates for 
individual 
countries 
ECDC/EuroHIV 
WHO Euro, UNAIDS 
Data 
protection 
Work with the Member 
States to identify possible 
practical problems with the 
protection of personal data 
and with the free movement 
of such data in the context of 
HIV/AIDS surveillance 
2006-2007     Commission 
ECDC/EuroHIV  
Member States 
Development 
of resistance 
Facilitate Europe-wide 
surveillance on HIV drug 
resistance  
2007-2008 Number  of 
countries 
implementing 
national HIV drug 
resistance 
surveillance 
ECDC/EuroHIV  
Commission 
Member States 
 
4. Prevention of new HIV infections 
                Area for action  Action  Indicative 
timetable 
Outcome/indicator  Main players 
                    Sexual transmission  1)  Develop  innovative 
strategy to promote safe 
sex and address the 
increase in risk-taking 
behaviour among youth 
2) Implement the strategy 
2006– 
 
 
 
2009- 
1) Innovative safe sex 
strategy developed 
 
 
2) Number of countries 
implementing the strategy 
Commission 
Member States 
Civil society 
organisations 
International 
organisations 
                  Mother-to-child 
                  transmission 
Report on the state of 
play in Europe 
2006 
 
Report followed by an 
action plan 
Commission  
ECDC/EuroHIV 
                  Harm reduction  Monitor  implementation 
of the Council 
Recommendation of 
2007 Report    Commission 
Member States  
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18 June 2003  
                                 Blood  Monitor  the  data 
compiled by Member 
States under the 
Commission Directive on 
traceability and adverse 
events and reactions 
(adoption expected in 
September 2005) related 
to transmission of HIV 
(and other diseases) by 
blood and blood 
components 
Annual 
reporting to 
Commission 
to begin by 
end of 2007 
Report Member  States 
Commission 
 
                                  Youth  Include  youth  as  a 
priority target group for 
the development of public 
health intervention  
2006-   Commission 
Member States 
Civil society 
organisations 
International 
organisations 
                                 Prisoners  Develop  HIV  prevention 
strategies for prisons 
Identify best practices for 
HIV prevention in prisons 
in Europe 
2006-  HIV prevention strategies 
developed for prisons  
Commission 
Member States 
Civil society 
organisations 
International 
organisations 
                  Population-wide 
                  information 
EBU “European health 
information platform” 
 
2006  Material for media 
Information website with 
updates, ready for use by 
TV and radio 
EBU and its partners 
Commission 
Member States  
 
                 Awareness-raising 
                 among general public 
1) Bring visibility to 
HIV/AIDS in Europe 
2) Link Europe into the 
World AIDS Campaign 
3) Promote prevention 
and Voluntary 
Counselling and Testing 
2006-2009 
May 
June/July 
 
December 
One to three EU-led events 
on HIV/AIDS every year 
Commission  
Member States 
ECDC/EuroHIV 
WAC  
Other partners 
                  Education  1)  Organise  a  consensus 
meeting on best practice 
2006  1) Consensus report   Commission  
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on HIV/AIDS peer 
education 
2) Develop a training 
module for HIV/AIDS 
peer education  
3) Implement the training 
module 
 
 
2006-2007 
 
2007-2009 
 
 
2) Training module 
 
3) Number of national 
HIV/AIDS focal points 
and peer education 
officials trained 
Member States 
WHO, UNAIDS, other 
partners 
 
 
5.Treatment, care and support 
Area for 
action 
Action  Indicative 
timetable 
Outcome  Main players 
Access of 
vulnerable 
groups to 
services 
 
1) Prepare a European 
inventory on best 
practices/know-how on drug 
treatments  
2) Prepare guidelines/best 
practices on access to 
treatment for vulnerable 
populations 
  1) Inventory of 
best practices  
2) Guidelines 
on access to 
treatment  
Commission 
Member States 
 
  Support capacity-building 
among service providers to 
improve access for vulnerable 
groups 
Continue the development of 
European curricula/training 
modules 
2006- Training 
programme for 
service 
providers 
Commission  
Member States 
Treatment 
preparedness 
Develop patient-friendly 
information on treatment 
 Number  of 
information 
packages 
developed 
Commission  
Member States 
NGOs 
  Develop a training module on 
treatment preparedness 
2006- Training 
module on 
adherence 
Commission 
Member States 
NGOs  
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Service 
standards 
Provide a toolkit for Member 
States for developing 
comprehensive HIV/AIDS 
services 
2006- Toolkit  for 
service 
standards 
 
Affordable 
ARV 
Continue exploring possible 
solutions 
 Feasible 
solution to 
reduce the cost 
of ARV 
Commission 
Pharmaceutical 
industry 
Member States 
concerned 
Laboratory 
capacity 
Training of 
personnel 
Integrate in curricula of 
university and continuing 
medical education  
   Commission, 
ECDC, 
Universities, 
Medical 
associations, 
ESCMID, WHO 
Euro 
Networking of 
laboratories for 
susceptibility 
testing 
Establish a Europe-wide 
network of national 
[reference] laboratories for 
HIV susceptibility testing 
  Network of 
specialist 
laboratories 
established 
ECDC 
Member States 
Upgrading 
national 
laboratories 
Assess the needs [training, 
equipment, etc.] in HIV 
laboratories at national level 
  Number of 
national 
inventories 
ready 
Member States 
ECDC 
 
6. Research 
Area for action  Action  Indicative 
timetable 
Outcomes  Main 
players 
Advance  treatment Establish a European 
network of clinical trials 
on new therapeutic 
approaches to HIV/AIDS 
2006-2010  New strategies for 
the management of 
HIV infection 
Member States 
Commission 
Facilitate 
vaccine/microbicide 
research 
Establish a European 
network for 
vaccine/microbicide 
research 
2006-2010  Standardisation of 
HIV research tools; 
new 
vaccine/microbicide 
candidates; closer 
European 
collaboration with 
global research 
initiatives and 
Commission 
Member States 
Research 
centres 
Industry, SMEs  
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partnerships 
Cohort  studies  Set up a network of 
European cohort studies 
on HIV/AIDS 
2006-2009  New treatment 
options to overcome 
resistance to HIV 
drugs; PMTCT
1 
Commission 
Clinical 
research centres 
 
                                                 
1 Prevention of mother-to-child transmission.  
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7. Neighbouring countries 
Area for 
action 
Action  Indicative 
timetable 
Outcomes  Main players 
Russian Federation 
  EC participation in the 
work of the Country 
Coordinating Mechanism  
2006-   EC  Delegation 
Russian Federation 
CCM 
Expert 
meetings on 
HIV/AIDS-
related issues 
1) Organise an expert 
meeting on HIV/AIDS 
2) Finnish Presidency 
meeting  
1) 2006  
2) 
September 
2006 
 1)  Commission 
Russian Federation 
Partners  
2) Council 
Presidency  
 
European Neighbourhood Policy partners 
  EC participation in the 
work of the Country 
Coordinating Mechanism 
2006-   EC  Delegation 
CCM 
ENP Partners 
Invite ENP 
partners to EU 
activities 
1) Invite ENP partners to 
Think Tank meetings on 
specific topics  
2) Invite ENP partners to 
HIV/AIDS-related 
meetings/conferences 
2006- Exchange  of 
information and 
best practises 
Commission 
Member States 
NGOs 
Partners  
Surveillance  Ensure that networks 
increasingly cover Southern 
Mediterranean countries 
2009 Surveillance  data 
available  
ECDC 
EpiSouth 
Explore the 
scope for 
specific 
HIV/AIDS 
meetings 
targeted at 
ENP partners 
Hold exploratory meeting 
with ENP Partners [in 
particular those with an 
ENP Action Plan] 
Hold a series of follow-up 
meetings on specific topics, 
2007 
 
 
2008- 
Exchange of 
information and 
best practises  
Commission 
Member States 
Partners   
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countries or regions 
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